Subscribe To

Price Alert Latest News Economic Calendar News

PHG / LAWSUITS FILED AGAINST PHG, ATIP and HYRE - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / October 8, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Read More

Demo Live Account See Partner Details

Content Topics

Lawsuits

Filed

Against

PHG

Atip

Hyre

Jakubowitz

Pursues

Shareholders

Claims

Stock

Posted: Oct 8 2021, 19:20

Author Name: Accesswire

PHG News

By Zacks Investment Research
October 24, 2023

Philips (PHG) Q3 Earnings Beat Estimates, Revenues Rise Y/Y

Philips' (PHG) third-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses.

By Investopedia
October 23, 2023

Philips' Profit Rises After Simplifying Operations and Shoring Up Its Supply Chains

American depositary receipts (ADRs) of Philips (PHG) advanced as the health technology firm posted better-than-expected results and raised its outlook

By TechXplore
October 23, 2023

Philips raises outlook despite sleep machine saga

Dutch medical device maker Philips raised its 2023 earnings outlook on Monday after posting stronger third quarter sales and profits despite a recent

By CNBC International TV
October 23, 2023

Philips CEO: China is having a tough time, but it has 'very bright' prospects

Philips CEO Roy Jakobs discusses the company's third-quarter results and the outlook for China.

By Reuters
October 23, 2023

Dutch health tech company Philips raises outlook as Q3 profit jumps

Dutch health technology company Philips on Monday raised its full-year outlook as it beat analyst expectations with a more than doubling of third-quar

By Zacks Investment Research
October 20, 2023

What's in the Cards for Koninklijke Philips' (PHG) Q3 Earnings?

Koninklijke Philips' (PHG) third-quarter results are likely to reflect strength in the Diagnosis & Treatment and Connected Care segments amid macroeco

By Zacks Investment Research
October 17, 2023

Philips (PHG) Aids Clinicians With New Monitoring Solution

Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confiden

By Seeking Alpha
October 12, 2023

Koninklijke Philips: Hold For Now

Exor recently entered Philips with a 15% equity stake (and optionality to arrive at 20%). PHG agrees to conduct additional testing and notes ongoing c

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.